# EDGAR Filing Document

**Accession Number:** 0001937993
**File Stem:** 0001213900-23-003079
**Filing Date:** 2023-1
**Character Count:** 4568
**Document Hash:** 6723e6095db58b6a1191a5a905ccc7b5
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-23-003079.hdr.sgml**: 20230117

**ACCESSION NUMBER**: 0001213900-23-003079

**CONFORMED SUBMISSION TYPE**: 8-A12B

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20230117

**DATE AS OF CHANGE**: 20230117

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Cadrenal Therapeutics, Inc.
- **CENTRAL INDEX KEY:** 0001937993
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **IRS NUMBER:** 880860746
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-A12B
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41596
- **FILM NUMBER:** 23532062

**BUSINESS ADDRESS:**
- **STREET 1:** 822 A1A NORTH
- **STREET 2:** SUITE 300
- **CITY:** PONTE VEDRA
- **STATE:** FL
- **ZIP:** 32082
- **BUSINESS PHONE:** 904-300-0701

**MAIL ADDRESS:**
- **STREET 1:** 822 A1A NORTH
- **STREET 2:** SUITE 300
- **CITY:** PONTE VEDRA
- **STATE:** FL
- **ZIP:** 32082

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, DC 20549**

**FORM 8-A**

**FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES**

**PURSUANT TO SECTION 12(b) OR 12(g) OF THE**

**SECURITIES EXCHANGE ACT OF 1934**

**CADRENAL THERAPEUTICS, INC.**

(Exact name of registrant as specified in its charter)

---

| | |
|:---|:---|
| **Delaware** | **88-0860746** |
| (State or other jurisdiction of<br> incorporation or organization) | (I.R.S. Employer<br> Identification Number) |
| **822 A1A North, Suite 306<br> Ponte Vedra, Florida 32082<br> (904) 300-0701** | **822 A1A North, Suite 306<br> Ponte Vedra, Florida 32082<br> (904) 300-0701** |
| *(Address of principal executive offices) (Zip Code)* | *(Address of principal executive offices) (Zip Code)* |

---

**Securities to be registered to Section 12(b) of the Act:**

---

| | |
|:---|:---|
| **Title of each class<br> to be so registered:** | **Name of each exchange on which<br> each class is to be registered:** |
| Common Stock, Par Value $0.001 Per Share | The Nasdaq Stock Market LLC |

---

If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c) or (e), check the following box. **☒**

If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d) or (e), check the following box. ☐

If this form relates to the registration of a class of securities concurrently with Regulation A offering, check the following box. ☐

Securities Act registration statement or Regulation A offering statement file number to which this form relates: **333-267562**

Securities to be registered pursuant to Section 12(g) of the Act: **None**

**INFORMATION REQUIRED IN REGISTRATION STATEMENT**

**Item 1. Description of Registrant's Securities to be Registered.**

The securities to be registered hereunder are shares of common stock, par value $0.001 per share (the "Common Stock"), of Cadrenal Therapeutics, Inc. (the "Registrant"). The description of the Common Stock contained in the section entitled "Description of Securities—Common Stock" in the prospectus forming a part of the Registration Statement on Form S-1, as amended (Registration No. 333-267562) (the "Registration Statement"), filed under the Securities Act of 1933, as amended (the "Securities Act"), is incorporated by reference herein. In addition, any description of the Common Stock contained in a form of prospectus relating to the Registration Statement subsequently filed by the Registrant pursuant to Rule 424(b) under the Securities Act shall be deemed to be incorporated by reference herein.

**Item 2. Exhibits.**

Under the Instructions as to Exhibits with respect to Form 8-A, no exhibits are required to be filed because no other securities of the Registrant are registered on The Nasdaq Stock Market LLC and the securities registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.

**SIGNATURE**

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **CADRENAL THERAPEUTICS, INC.** | **CADRENAL THERAPEUTICS, INC.** |
| Date: January 17, 2023 | By: | /s/ Quang Pham |
|  | Name: | Quang Pham |
|  | Title: | Chairman of the Board and Chief Executive Officer |

---